Back to Results
First PageMeta Content
Research / Biosimilar / Biotechnology / Drugs / Pharmaceutical industry / Biologic / European Medicines Agency / Summary of Product Characteristics / Patient information leaflet / Pharmacology / Pharmaceutical sciences / Clinical research


Labelling & Naming – European Biosimilars Group (EBG) perspective >400 Million patient days worldwide clinical experience with EU biosimilar medicines
Add to Reading List

Document Date: 2014-12-27 09:47:37

Open Document

File Size: 1,93 MB

Share Result on Facebook

Company

Drug Information Association Inc. / European Biosimilars Group / Disclaimer / /

Continent

Europe / /

Country

United States / /

IndustryTerm

clear and transparent product / reference medicinal product / reference products / biosimilar products / healthcare professionals / individual biological product / reference product / medicinal products / biological medicinal product / sector / biosimilar product / /

MedicalTreatment

medication errors / /

Organization

Speaker’s Bureau / European Union / European Medicines Agency / /

Person

Patent Holder / Elke Grooten / /

Position

extensive head / Director Public Affairs Sandoz Europe Member / /

SocialTag